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Abstract 
 
Background: Diabetes mellitus (DM) is one of the most common disorders of endocrine glands which has a 
worldwide distribution and is a risk factor for oral pathology so; the purpose of the present study was to investi-
gate the association between median rhomboid glossitis (MRG) and DM. 
 
Methods: We examined 202 Iranian patients with DM aged 10-86 years and 261 healthy subjects aged 10-28 
years and the diagnosis of MRG was made based on clinical features. 
 
Results: The examination indicated that 13 (6.43%) diabetic patients and 4 (1.53%) of control group had MRG. 
There was a significant difference in the prevalence of MRG, between patients and control group. MRG showed 
no association with other variables (age, sex, duration of DM, drugs, FBS, A
1C). 
 
Conclusion: In the present study the prevalence of MRG in diabetics was much higher than that of controls. 
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Introduction 
 
The term "diabetes mellitus" is used to identify a 
group of disorders characterized by elevated level of 
glucose in the blood. This elevation is as result of de-
ficiency in insulin secretion or an increased cellular 
resistance to the actions of insulin, leading to a varie-
ty of metabolic abnormalities involving carbohy-
drates, fats and proteins.
1 In 1997, the American As-
sociation of Diabetes proposed a classification system 
for diabetes based on its etiology. Therefore, diabetes 
is currently classified as: Type 1 or juvenile diabetes 
and Type 2 or acquired diabetes. Type 1 diabetes ap-
pears in the first or second decade of life, it is caused 
by the destruction of pancreatic beta cells, which can 
be caused by a viral or an autoimmune process lead-
ing to blockade in the production of insulin.
2 On the 
other hand, type 2 diabetes is the result of an abnor-
mality that can occur both at the molecular level of 
insulin and at the cellular level of insulin receptors.
2  
The complications of diabetes that contribute to 
morbidity and mortality include microvascular diseas-
es, macrovascular diseases, in particular cardiovascular 
diseases and perioral diseases. In addition, diabetes 
increases the risk of oral pathology including acute 
infections, periodontitis, and possibly premalignant 
and malignant lesions.
3  The most common oral mani-
festations in diabetic patients include xerostomia, burn-
ing and eventual erythema, and ulcerations, pharyngeal 
infections caused by Candida albicans, cheilitis, Li-
chen planus, gingival problems, periodontal problems, 
abscesses and marked loss of alveolar bone, although 
none of them is a pathognomonic lesion.
4  
Diabetes is a far reaching epidemic that creates 
morbidity and mortality for millions of people in both 
developed and developing countries. Therefore, it is 
necessary that health care professionals become inter-
ested on the disease in order to provide an appropriate 
treatment to these patients in the different fields of 
knowledge. Median rhomboid glossitis, first de-
scribed by Borcq in 1914, occurs in less than 1% of 
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general population.
5 About 70-80% of cases are in 
men.
6 Its etiology is unknown, althovgh it has been 
proposed that it may be derived from chronic candidia-
sis, or that it may be of embryological, inflammation, 
Staph aureus or even an immunological origin.
5 
It typically presents in the posterior region of the 
dorsum of the tongue, at the midline, anterior to the 
lingual "V”, however, it sometimes appears in para-
medial location.
6 It appears as a rounded or rhomboid 
painless plaque with well-defined margin, intense 
reddish or pinkish in color due to atrophy or depapil-
lation and firm to palpation.
5 Due to complications of 
DM including the increase of susceptibility to many 
infections such as oral candidiasis, the purpose of the 
present study was to investigate the association be-
tween MRG and DM. 
 
 
Materials and Methods 
 
The subjects in this study were 202 Iranian patients 
with DM (Type 1 and type 2) aged 10-86 years. All 
of them were referred from Valfajr Clinic and Oral 
Medicine Department of Shiraz Medical School (Shi-
raz, Iran). Control cases were 261 healthy subjects 
aged 10-82 years with no signs and symptoms of any 
disease who were sex and age matched. Data regard-
ing age, sex, duration of DM, drug used, and paraclin-
ical data including FBS, Hb A
1C and 2HPP, 4PM, 
11AM were recorded in patients with DM. 
All subjects were informed about the research 
character and agreed to participate on the study by 
signing the free and informed consent form. The sub-
jects were examined clinically by two trained exam-
iners using artificial light, mouth mirror, gauze, etc; 
and the diagnosis was made based on clinical fea-
tures, according to WHO guidelines. Results were 
analyzed with SPSS software (Version 11.5, Chicago, 
IL, USA), and T, Chi-Square and Fisher Exact tests 
were used to compare the results. 
 
 
Results 
 
A total of 463 individuals, including 202 patients with 
DM (51 males and 151 females) and 261 controls (76 
males and 185 females) were recruited into this study. 
The mean age of DM group was found to be 
56.1±11.2 years and the control group 54.5± 13.4 
years. In the present study, examination indicated that 
13 (6.43%) of the diabetic patients and 4 (1.53%) of 
control group had MRG (Figure 1). 
 
 
Fig. 1: MRG in a diabetic patient 
 
Four (7.84%) diabetic male and 5.9% (n=9) of diabet-
ic females had MRG. This figure was 1.31% (n=1) 
and 1.62% (n=3) in the control group respectively. 
There was a significant difference in the prevalence 
of MRG, between patients and controls (p=0.005). 
MRG showed no association with other variables 
(age, sex, duration of DM, drugs, FBS, A
1c) (Table 1). 
Table 1: Data recorded in diabetic patients with and without MRG
Parameter MRG 
+ 
MRG
- 
P value 
Age  47.3811.2 50.9613.9  0.3 
Duration of DM  10.548.2 9.27.9  0.5 
Glibenclamid 8  88  0.3 
Metformin 5  93  0.4 
Glutazone 0  25  0.1 
Acarbose 0  18  0.2 
Insulin level  4  56  0.9 
FBS  235118 18178  0.1 
Hb A
1C  9.250.44 8.61.6  0.4 
 Median rhomboid glossitis 
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One of the subjects in the control group, showed kiss-
ing lesion in the palate. 
 
 
Discussion  
 
Diabetes mellitus is one of the most common disor-
ders of endocrine glands which has a worldwide dis-
tribution, occurring in about 1 to 2% of the word 
population, and it is more prevalent in well fed popu-
lations because they have better access to mostly 
high- calorie foods.
2 Diabetes is a risk factor for oral 
pathology including gingivitis, periodontitis, candidi-
asis, oral lichen planus, premalignant lesions like leu-
koplakia and oral malignancies.
7,8 In this study the 
prevalence of MRG in diabetic patients was 6.43% in 
comparison to 1.53% in the control group. It occurred 
with significantly more prevalence in our subjects 
with DM than in control subjects and its prevalence 
was similar to another study in Iran which report the 
prevalence of MRG to be 7% in diabetic patients.
9  
Guggenheimer et al. reported that more subjects 
with insulin-dependent diabetes mellitus (IDDM) 
than control subjects without IDDM (15.1% vs 3.0% 
were found to have clinical manifestations of candidi-
asis, including MRG, denture stomatitis and angular 
chelitis.
10 The prevalence of MRG was 7% in their 
study which was similar to the present study. Farman 
observed that atrophic lesion of the tongue were 
found in 26.4% of the diabetic patients and 91.7% of 
these lesions were MRG. They reported that the prev-
alence of MRG in diabetics was much higher than 
that of MRG found in previous investigations among 
other populations. They suggested that patients with 
MRG should be screened to rule out diabetes mellitus 
as the underlying cause.
11  
Ponte et al. reported that among the inflammatory 
manifestations of the oral mucosa found in diabetes, 
glossitis deserve especial attention. Probably as a 
consequence of higher frequency of Candida albicans 
infection and microvascular changes, diabetics have a 
higher frequency of atrophic tongue lesions (central 
papillary atrophy) and of geographic tongue.
12 MRG 
is a recognized manifestation of chronic candidiasis.
11 
It is well known that uncontrolled diabetes predis-
poses to a variety of superficial and systemic infections, 
and oral candidiasis in particular is thought to be more 
prevalent among these individuals. The course of infec-
tion is also more complicated in these patients group.
13 
The mechanism by which diabetes predisposes to 
high candidial infections is not yet established. How-
ever it is widely recognized that high salivary glucose 
levels in diabetic patients favors yeast growth,
10,14 but 
Quirino et al. linked this high frequency of Candida 
albicans infections with hyposalivation.
15 In the pre-
sent study, 7.84% of diabetic males and 5.9% of dia-
betic females had MRG and MRG showed no associ-
ation with other variables (age, sex, duration of DM 
drugs, FBS and A
1C). 
Hoseinpoor showed that none of the males and 
8.6% of the females had MRG.
9 Guggenheimer et al. 
reported that diabetic subjects with MRG were more 
likely to have a longer duration of IDDM and MRG 
was also significantly associated with older age, male 
gender and diabetic complications of nephropathy 
and retinopathy.
10 In the present study, the prevalence 
of MRG in diabetics was found to be much higher 
than that of controls.  
Diabetes is a prevalent disease that causes multiple 
co-morbidities. Oral pathologies are complications of 
diabetes that will bring these patients to the attention 
of oral health practitioners. Many of these individuals 
will have undiagnosed diabetes or uncontrolled diabe-
tes, and the oral medicine physician can be critical in 
making the diagnosis counseling the patient in the 
importance of diabetes control and referring the pa-
tient to an endocrinologist for farther management. 
For this reason, the oral medicine physician can 
have a major impact on both the diagnosis and control 
of this common disease, there by improving the lives 
of individuals with diabetes. 
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